| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824379 | Clinical Therapeutics | 2016 | 12 Pages |
Abstract
This study revealed PK equivalence between SB3 and EU trastuzumab, between SB3 and US trastuzumab, and between EU trastuzumab and US trastuzumab. SB3 is well tolerated without tolerability concerns after single-dose administration in healthy male subjects.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Xavier MD, PhD, Elsa MD, Yoon Jung PhD, George MD, Anke MD, Donghoon MD, PhD, Youngdoe MS, Hansook MS, Rainard MD, PhD,